Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone Titration vs Standard Practice in Advanced Cancer Pain
NCT03024515Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Aug 2018
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of oxycodone in cancer pain (2 arms), sponsored by The Chinese University of Hong Kong. Primary endpoint: Time to stabilization of pain control during titration phase at 1 year. Started Aug 2018; status: completed.
02
Drugs
oxycodone
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT03024515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03024515.